Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Infection and Immunity
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About IAI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacterial Infections

Identification of Burkholderia cenocepacia Strain H111 Virulence Factors Using Nonmammalian Infection Hosts

Stephan Schwager, Kirsty Agnoli, Manuela Köthe, Friederike Feldmann, Michael Givskov, Aurelien Carlier, Leo Eberl
J. B. Bliska, Editor
Stephan Schwager
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kirsty Agnoli
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuela Köthe
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Friederike Feldmann
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Givskov
bDepartment of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
cSingapore Centre on Environmental Life Sciences Engineering, Nanyang Technological University, Singapore, Republic of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aurelien Carlier
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leo Eberl
aDepartment of Microbiology, Institute of Plant Biology, University of Zurich, Zurich, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. B. Bliska
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/IAI.00768-12
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Burkholderia cenocepacia H111, a strain isolated from a cystic fibrosis patient, has been shown to effectively kill the nematode Caenorhabditis elegans. We used the C. elegans model of infection to screen a mini-Tn5 mutant library of B. cenocepacia H111 for attenuated virulence. Of the approximately 5,500 B. cenocepacia H111 random mini-Tn5 insertion mutants that were screened, 22 showed attenuated virulence in C. elegans. Except for the quorum-sensing regulator cepR, none of the mutated genes coded for the biosynthesis of classical virulence factors such as extracellular proteases or siderophores. Instead, the mutants contained insertions in metabolic and regulatory genes. Mutants attenuated in virulence in the C. elegans infection model were also tested in the Drosophila melanogaster pricking model, and those also attenuated in this model were further tested in Galleria mellonella. Six of the 22 mutants were attenuated in D. melanogaster, and five of these were less pathogenic in the G. mellonella model. We show that genes encoding enzymes of the purine, pyrimidine, and shikimate biosynthesis pathways are critical for virulence in multiple host models of infection.

INTRODUCTION

The Burkholderia cepacia complex (Bcc) consists of 17 closely related, but phenotypically diverse, bacterial species. Strains of the Bcc have been isolated from soil, the rhizospheres of plants, groundwater, industrial settings, hospital environments, and infected humans and animals. Some strains could be valuable for biotechnology, as they can be used for bioremediation, as biological pest control agents, and for plant growth promotion. Conversely, some strains from the Bcc can act as problematic opportunistic pathogens in patients suffering from cystic fibrosis (CF) and also in immunocompromised individuals (1–4). B. cenocepacia and Burkholderia multivorans are currently the Bcc species most frequently isolated from clinical samples (1, 4). In CF patients these species can cause serious infections, leading to rapid decline in lung function and an often fatal pneumonia (known as “cepacia syndrome”) (5, 6).

Over the past decade, substantial progress has been made in identifying and characterizing the virulence determinants and infection mechanisms of Bcc strains (7). These studies used different Bcc strains and various infection models. Since strain-to-strain variability and the infection model used have a tremendous effect on the outcome of pathogenicity assays, knowledge of the importance of individual virulence factors in different infection hosts is sparse (7, 8).

In this study, we screened a Burkholderia cenocepacia H111 random insertion mutant bank for attenuated virulence in Caenorhabditis elegans. To exclude experimental and host-specific factors, other nonmammalian animal models were used to test those mutants which showed attenuation in pathogenicity to C. elegans. The first was the fruit fly, Drosophila melanogaster, into which bacteria were injected by pricking with a needle (9, 10). Those mutants that were also attenuated in D. melanogaster were further tested using the greater wax moth larva Galleria mellonella, which allows injection of a precise dosage of bacteria (8, 11). We checked mutants for the production of AidA, which is known to play a role in pathogenicity to C. elegans (8, 12), as well as for other previously identified virulence factors, including production of acyl-homoserine lactone (AHL) signal molecules, siderophores, proteases, and polysaccharides.

MATERIALS AND METHODS

Organisms and culture conditions.Bacterial strains and plasmids used in this study are listed in Table 1. Unless otherwise stated, bacteria were grown at 37°C in modified Luria-Bertani (LB) broth (13) containing 5 g NaCl liter−1. Solid media contained agar to a final concentration of 1.5%. Antibiotics were added as required at final concentrations of 20 μg ml−1 gentamicin, 50 μg ml−1 kanamycin, 10 μg ml−1 tetracycline, 50 μg ml−1 spectinomycin, 25 μg ml−1 streptomycin, and 10 μg ml−1 chloramphenicol. Growth of liquid cultures was monitored by measurement of optical density at 600 nm (OD600) using an Ultraspec 3100 pro (Amersham Bioscience). Supplements were added to media to the following concentrations: l-histidine, l-cysteine, dl-tryptophan, and adenosine, 500 μM; guanine, adenine, adenosine, and inosine, 20 μg liter−1. Killing assays were performed using Caenorhabditis elegans strain Bristol N2, which was obtained from the Caenorhabditis Genetics Center (University of Minnesota, St. Paul, MN). Nematodes were maintained on NG agar (14) at 20°C with Escherichia coli strain OP50 as a food source (15). For the D. melanogaster pricking assay, the D. melanogaster Canton-S wild-type strain was used. The flies were kept at room temperature and fed with standard sucrose cornmeal (http://flystocks.bio.indiana.edu/Fly_Work/media-recipes/harvardfood.htm). G. mellonella was bought from Fischerei Brumann, Zurich, Switzerland, and kept in an incubator at 14°C. The larvae were used within 3 weeks of purchase.

View this table:
  • View inline
  • View popup
Table 1

Bacterial strains and plasmids used in this study

Transposon insertion mutagenesis.The hybrid transposon (Table 1) was randomly inserted into the genome of B. cenocepacia H111 by triparental mating as described previously (24). Transconjugants were selected on LB medium containing kanamycin and tetracycline. These random insertion mutants were picked and grown in 150 μl LB medium in polypropylene microtiter plates (Nunc). For storage, 75 μl of 50% (vol/vol) glycerol was added and the plates were frozen at −80°C.

DNA manipulations and sequence analysis of Tn5 mutants.Cloning, restriction enzyme analysis, and transformation of E. coli were performed essentially as described previously (16). PCR was performed using TaKaRa rTaq DNA polymerase (TaKaRa Shuzo), as per the manufacturer's instructions. Plasmid DNA was isolated with the QIAprep Spin Miniprep kit (Qiagen), and chromosomal DNA from B. cenocepacia was purified with the DNeasy tissue kit (Qiagen). DNA fragments were purified from agarose gels using the QIAquick gel extraction kit (Qiagen).

To ensure that the attenuated mutants bore only one transposon, Southern blotting was employed. Genomic DNA was digested with SphI. The fragments were electrophoresed through a 1% agarose gel and transferred using a blot apparatus (Stratagene, Heidelberg, Germany) to a positively charged nylon membrane (Hybond-N+; Amersham, Cleveland, OH). The transferred DNA was UV fixed, and the blots were hybridized with a digoxigenin (DIG)-coupled probe. The probe was prepared and detected using DIG High-Prime DNA labeling and detection starter kit I (Roche, Mannheim, Germany) according the manufacturer's instructions. Probes for the detection of the transposons were constructed by PCR amplification of the Tn5 kanamycin cassette using Kan res-v and Kan res-r primers (17) (Table 2).

View this table:
  • View inline
  • View popup
Table 2

Primers used in this study

The insertion position of the transposon was determined by two different techniques, SphI cloning and arbitrary PCR. DNA sequences flanking transposon insertions were determined by arbitrary PCR as described previously (18), with some modification. Briefly, we performed two rounds of PCR amplification using a degenerate arbitrary primer to anneal to the chromosome and one specific to the mini-Tn5 transposon. Primers used in the first round were ARB6 and luxCext2 (Table 2). First-round reaction conditions were as follows: (i) 5 min at 95°C; (ii) 6 cycles of 30 s at 95°C, 30 s at 30°C, and 1 min at 72°C; (iii) 30 cycles of 30 s at 95°C, 30 s at 45°C, and 1 min at 72°C; and (iv) 5 min at 72°C. The second round of PCR amplification used 5 μl purified first-round PCR product as the template and primers ARB2 and luxCint2 (Table 2). Second-round reaction conditions were as follows: (i) 30 cycles of 30 s at 95°C, 30 s at 45°C, and 1 min at 72°C, and (ii) 5 min at 72°C. The PCR products were purified from an agarose gel and ligated into the vector pCR 2.1-TOPO.

Sequencing reactions were carried out to determine the transposon integration sites using the Seq_O primer (Table 2), which binds to the O end of the mini-Tn5 transposon. Integration sites were determined using the online BLAST search engine (http://www.ncbi.nlm.nih.gov./).

For the SphI cloning, genomic DNA was digested with SphI. This cleaved the i end of the transposon, including the kanamycin resistance gene. The digested DNA was cloned into pUC19 and transferred into E. coli DH5α. Bacteria containing a transposon fragment were selected on LB plates containing kanamycin. The sequence of the inserted DNA was found by sequencing with standard M13 primers, Kan res-v and Kan res-r (Table 2).

Complementation of the Tn5 mutants using a B. cenocepacia H111 cosmid library.Chromosomal DNA was extracted from B. cenocepacia H111 using a standard protocol (19). The DNA was partially digested with EcoRI and ligated into cosmid pRG930 (20). Packaging and of the cosmid into E. coli HB101 cells and titer determination were carried out using the Gigapack III Gold packaging reaction kit from Invitrogen as described in the instruction manual but with the omission of the dilution step of the titer determination reaction. The whole cosmid library was pooled and introduced into each transposon mutant by triparental mating (21). Complemented mutants were selected on ABC minimal plates containing streptomycin and spectinomycin. Cosmids were then extracted using a miniprep kit (Qiagen) and the cosmid ends sequenced with the primers pRG930_seq_rv and pRG930_seq_fw (Table 2) to determine the extent of the genomic insert.

Pathogenicity screen with C. elegans.Screening was carried out on NG agar plates as described previously (22, 23). H111 mutants were grown at 37°C overnight in LB broth in microtiter dishes (Nunc). Fifty microliters of the respective cultures was spread on NG agar plates in 24-well multiplates (Greiner, Germany). Plates containing bacteria were incubated overnight at 37°C. After a brief incubation at room temperature to allow cooling, plates were inoculated with 20 to 30 synchronized L4 worms of the C. elegans Bristol N2 wild-type strain (obtained from the Caenorhabditis Genetics Center, University of Minnesota, Minneapolis, MN) (24). The plates were then incubated at 20°C, and live worms were counted after 2 days. In the initial screen approximately 230 24-well plates were tested in a single replicate. All mutants identified in the initial screen were retested in five independent replicates.

G. mellonella killing assays.The G. mellonella infection assay was performed as described previously (8). Modifications were made to the protocol as follows. To prevent contamination, the Tn5 mutants' growth medium was supplemented with kanamycin. For hemolymph extraction, larvae were first sterilized by brief immersion in absolute ethanol. Hemolymph was removed using a syringe with a 22-gauge needle. Approximately 100 μl was obtained per larva. Dilutions were plated for bacterial enumeration. Caterpillars in the final larval stage were purchased from Fischerei Brumann, Zurich, Switzerland.

D. melanogaster pricking assays.D. melanogaster Canton-S wild-type flies were used for the pricking procedure. The flies were bred on standard cornmeal sucrose medium and kept at room temperature. The assay was performed as described previously (10). Modifications were made to this protocol as follows. Two- to 9-day-old male and female flies were used in this experiment. For anesthetization, ether was used instead of a CO2 pad. For each trial, duplicate sets of 15 flies were used and the experiment was performed in triplicate. The negative-control flies were inoculated with a 10 mM MgSO4 solution. If more than 5 flies died due to pricking injury, the experiment was repeated. The infected flies were incubated at 26°C.

AHL quantification.Strains were grown to an OD600 of 3.0. Bacteria were collected by centrifugation at 6,500 rpm for 5 min and the supernatant filter sterilized. One hundred microliters of supernatant was mixed with 100 μl exponential-growth-phase Pseudomonas putida F117(pAS-C8-Gmr). This strain is highly specific for C8 homoserine lactone (HSL) detection. Commercial C8 HSLs were used as a standard. The cells were incubated in FluoroNunc Polysorp microtiter plates (Nunc Roskilde) for 6 h in the dark at 30°C. Fluorescence was measured with a Lamda Fluoro 320 Plus reader (Bio-Tek Instruments, Winooski, VT), and the relative fluorescence units (RFU) were determined.

Determination of siderophore production and extraction of pyochelin.Siderophore activity of the H111 mutants was tested on CAS agar as described previously (25). CAS plates were inoculated with 5 μl culture at an OD600 of 1.0, allowed to dry, and incubated at 37°C for ∼48 h. Siderophore activity was determined by comparison of halo diameter (a larger halo indicates higher siderophore production) and color (25, 26).

For pyochelin extraction, mutants were grown overnight in 200 ml NG medium to reflect the growth conditions used for the initial identification of mutants attenuated in virulence to C. elegans. This ensured both the growth of the mutants and the relevance of the results to pathogenicity in the C. elegans model. Bacteria were collected by centrifugation, and the pH of the spent culture supernatants was adjusted to ∼2.0 by the addition of HCl. The siderophores were extracted twice by addition of 0.4 volume dichloromethane. The organic phase was removed by rotary evaporation, and the residue was resuspended in 200 to 250 μl methanol.

The extracts were analyzed by thin-layer chromatography on silica 60 plates (VWR) with chloroform-acetic acid-ethanol at 90:5:2.5 (vol/vol) as the solvent (27). Plates were dried after development and siderophores detected by UV light. Pyochelin was identified by the presence of two yellow-green fluorescent bands corresponding to the two pyochelin stereoisomers, pyochelins I and II (Rfs, 0.35 and 0.37, respectively), and salicylate was visualized as a blue fluorescent band (Rf, 0.74) (28, 29).

Determination of protease activity and EPS production.Protease activity was determined on skimmed milk agar as described previously (30). Five microliters of overnight culture from each strain to be tested (diluted to an OD600 of 1) was dropped onto the plate and allowed to dry. The plate was incubated at 37°C for 48 h. Extracellular polysaccharides (EPS) production was determined on YEM agar supplemented with Congo red (31). EPS-positive strains showed a slimy, slightly red colony morphology after overnight incubation at 37°C, whereas EPS-negative strains turned red as a result of integration of the dye.

Production of AidA.Detection of AidA was performed by Western blotting. Whole-cell proteins were separated on a 15% SDS-polyacrylamide gel and then transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P; Millipore, Eschborn, Germany). Anti-AidA antibodies (12) were used to probe the membrane. Detection reactions were performed with alkaline phosphatase-conjugated anti-rabbit immunoglobulin G (Sigma, Steinheim, Germany) according to the recommendations of the manufacturer (Roche, Mannheim, Germany).

Growth on minimal media.The growth of the transposon mutants was tested using ABC or ABG minimal medium (32). For growth tests, 5 ml of ABC or ABG solution was inoculated with bacteria to an OD600 of 0.01 and incubated at 37°C with shaking. For the functional complementation (supplementation) of the purine mutants, 20 mg liter−1 adenine, inosine, or guanine was added to ABC minimal medium.

RESULTS

Identification of B. cenocepacia H111 mutants attenuated in C. elegans and their phenotypic characterization.It has previously been shown that on NG medium the CF isolate B. cenocepacia H111 kills C. elegans N2 within 3 days. We employed this “slow-killing” assay to screen a collection of approximately 5,500 random mini-Tn5 insertion mutants of B. cenocepacia H111 for attenuated virulence. In total, 23 mutants that reproducibly showed reduced killing after 48 h compared with the wild type were isolated (Fig. 1; Table 3). Previous work has identified several factors that contribute to the pathogenicity of B. cenocepacia (7), and we therefore tested the mutants for the production of some of these factors, including siderophores, extracellular polysaccharides (EPS), proteases, AHL quorum-sensing (QS) signaling molecules, and AidA, a protein required for nematode pathogenicity (Table 3).

Fig 1
  • Open in new tab
  • Download powerpoint
Fig 1

Virulence of wild-type B. cenocepacia H111 and auxotrophic mutants in the C. elegans model. C. elegans were counted 48 h after spreading the worms on medium covered with a lawn of the respective bacterial strain. Each experiment consisted of three independent replicates. Black bar represents the wild type (wt) (H111), dark gray bars represent mutants grown on NG medium, and light gray bars represent mutants grown on nutritionally supplemented NG medium. Nutritional supplementation was as follows: hisG and hisH, histidine; cysI and cysB, cysteine, trpA, trpB, and trpF, dl-tryptophan; purD, purF, purL, and purA, adenosine.

View this table:
  • View inline
  • View popup
Table 3

B. cenocepacia H111 mutants attenuated in C. elegans

B. cenocepacia H111 produces the two siderophores ornibactin and pyochelin, which were previously shown to be important for virulence in mammals, C. elegans, and larvae of the greater wax moth G. mellonella but not alfalfa (8, 33, 34). Some of the mutants showed reduced siderophore production (Table 3). In addition, we observed that some of the mutants formed a yellow rather than a pink halo on CAS agar (Fig. 2A), which is indicative of a loss of pyochelin production (35). Extraction of culture supernatant and analysis by thin-layer chromatography confirmed that these mutants produced no or reduced amounts of pyochelin (Fig. 2B).

Fig 2
  • Open in new tab
  • Download powerpoint
Fig 2

Siderophore production of attenuated B. cenocepacia H111 Tn5 mutants. (A) Mutants were inoculated on CAS plates and incubated at 37°C for 48 h. The halo diameter corresponds to siderophore activity. A pink-tinted halo is indicative of pyochelin production. (B) Production of pyochelin as determined by thin-layer chromatography. Bands corresponding to pyochelins I and II (P1/P2) and salicylate (SA) are indicated. Extracts were as follows: SA, salicylate standard; wt, wild-type H111; cysI, H111 cysI; aroK, H111 aroK; cepR, H111 cepR.

The production of extracellular polysaccharides (EPS) is considered to enhance persistence of Bcc species in the lung, similar to alginate in Pseudomonas aeruginosa (36, 37). We tested the attenuated mutants for EPS production on YEM agar, which stimulates the production of the major Bcc polysaccharide cepacian (38, 39). Many of the attenuated mutants showed reduced EPS production (Table 3). However, a defined cepacian-deficient mutant of B. cenocepacia K56-2 was found to be as pathogenic as the wild type in C. elegans and in G. mellonella (data not shown), suggesting that the lack of EPS production is not responsible for the reduced virulence of our mutants. It should be noted that cepacian production has been shown to be important for pathogenicity in murine infection models (40, 41). Furthermore, our phenotypic characterization revealed that several of the mutants produced no or reduced amounts of AHL signal molecules, proteases, or AidA (Table 3).

Mutant D6 grew slower in LB medium, whereas the growth rates of the other mutants were indistinguishable from that of the wild type (see Fig. S1 in the supplemental material). In contrast to the wild type, however, many of the mutants showed poor or no growth on minimal medium supplemented with either glucose or citrate as a carbon source and thus were auxotrophic mutants.

Locations of transposon insertions within the attenuated mutants.The locations of the transposon insertions were determined by sequencing the DNA regions flanking the transposon (Table 3). To our surprise, only one of the disrupted genes coded for a previously described virulence factor (the QS regulator CepR), while 19 of the mutations were in metabolic genes, three mutations were in regulatory genes, and three mutants were found to have lost an entire replicon (R12, R33, and R40). The latter three mutants have been described elsewhere (42).

Four of the genes identified in the transposon screen (cepR, lon, rsuA, and rsaM) code for regulatory proteins. The isolation of a cepR mutant is in full agreement with previous work that has demonstrated that the QS regulator CepR is essential for virulence in multiple infection hosts (8). One mutant was found to carry the transposon insertion in the rsuA gene. An rsuA mutant was previously identified in a screen for biofilm-defective mutants, and this gene (previously known as yciL) has been characterized as a higher-level quorum-sensing (QS) regulator (43). The transposon insertion site of another mutant that was affected in QS was mapped to the intergenic region between the divergent rsaM and cepR genes, such that expression of both genes is affected (data not shown). Finally, the lon gene codes for an ATP-dependent protease which belongs to the AAA+ (ATPases associated with a variety of cellular activities) superfamily of enzymes (44). This is a widespread family of enzymes (45), responsible for diverse functions, including protein unfolding, DNA replication, and recombination (44). Disruption of the lon gene has been shown to reduce the pathogenicity of Salmonella enterica (46), Pseudomonas syringae (47), Campylobacter jejuni (48), Agrobacterium tumefaciens (49), and Brucella abortus (50). This appears to be due to the role of Lon in the upregulation of type three secretion systems (44, 51, 52).

The 19 mutants defective in metabolic functions had mutations that fell within three major pathways: the purine biosynthetic pathway, the shikimate pathway, and the pyrimidine biosynthetic pathway. Four of the attenuated mutants identified during the C. elegans screen carried insertions within genes of the purine biosynthesis pathway (purA, purF, purL, and purD) (Fig. 3), suggesting that de novo purine biosynthesis plays an important role in the nematode pathogenicity of B. cenocepacia H111. The purF, purD, and purL genes are all positioned in the initial part of the purine biosynthetic pathway (Fig. 3), and upon inactivation of any of them, one would expect complete abrogation of purine production. The purA gene, however, is positioned later in the pathway and would not be necessary for the production of guanine- and xanthine-related purines. IMP is the first molecule containing the purine double-ring system to be formed in the purine pathway. This molecule can be used in the production of both adenine and guanine by the cell (53, 54) (Fig. 3). Growth of the purD, purF, and purL mutants could be successfully restored by the addition of inosine to ABC minimal medium (Fig. 4C, D, and E). Supplementation with adenine, but not with guanine, restored growth to these mutants in ABC minimal medium (Fig. 4C, D, and E). Adenine can be converted to guanine via the purine metabolic pathway, but the reciprocal conversion is not possible via this pathway. The addition of inosine, adenine, and guanine to ABC medium did not affect the growth of wild-type H111 (Fig. 4A).

Fig 3
  • Open in new tab
  • Download powerpoint
Fig 3

The B. cenocepacia purine biosynthetic pathway. Mutants with attenuated virulence isolated in this study are circled.

Fig 4
  • Open in new tab
  • Download powerpoint
Fig 4

Growth of purine mutants in ABC medium supplemented with various metabolites. Tubes: 1, unsupplemented medium; 2, supplementation with inosine; 3, supplementation with adenine; 4, supplementation with guanine; 5, supplementation with adenine and guanine. (A) B. cenocepacia HIII; (B) purA mutant; (C) purD mutant; (D) purF mutant; (E) purL mutant.

The pyrD and aroK mutants showed very similar phenotypic characteristics (Table 3). The pyrD gene codes for a class 2 dihydroorotate dehydrogenase, which is a key component in pyrimidine metabolism. The aroK gene encodes a component of the shikimate pathway, through which chorismate, an important precursor in the production of aromatic amino acids, is produced. Another mutant was disrupted in ilvC, a ketol-acid reductoisomerase, which plays a role in valine, leucine, and coenzyme A biosynthesis.

Of the remaining metabolic mutants, 10 had defects in amino acid biosynthesis. Four cysteine pathway mutants were all disrupted in the cysI gene (which codes for the beta subunit of a sulfide reductase), and one mutant bore an insertion in the cysB gene (a potential transcriptional regulator of the cys regulon). Two additional genes that play a role in the histidine metabolic pathway, hisG (encoding an ATP-phosphoribosyltransferase), and hisH (encoding a glutamine-amidotransferase), were found to be important for pathogenicity in the C. elegans model, as were the tryptophan biosynthetic pathway genes trpA, trpB, and trpF [encoding tryptophan-synthase alpha and beta chains and N-(5′-phosphoribosyl)anthranilate-isomerase, respectively].

The final two metabolic mutants bore insertions in genes not directly involved in amino acid biosynthesis; the ahcY (S-adenosylhomocysteine hydrolase) gene, the product of which acts as a coenzyme in cysteine and methionine metabolism, and the gatA (glutamyl-tRNA amidotransferase subunit A) gene, which plays a role in protein synthesis.

Five of the mutants attenuated in C. elegans are also less virulent in D. melanogaster and G. mellonella.Previous work has shown that some virulence factors are host specific, while other factors are important for pathogenicity in multiple infection models (8). We tested the 23 mutants showing attenuation in the C. elegans pathogenicity assay using the D. melanogaster infection model to discern host-specific and general factors. The fruit fly D. melanogaster has been shown to be a useful nonmammalian infection host for the determination of the pathogenicities of different Bcc strains (9). Of the 23 mutants with reduced C. elegans virulence, six were also strongly attenuated in the D. melanogaster infection model (Fig. 5). These six mutants were further tested for virulence using larvae of the greater wax moth G. mellonella as a host in order to validate their function as general virulence factors (Fig. 6). Five of the six mutants were attenuated compared to the wild type in this model, namely, the purD, purF, and purL purine biosynthesis mutants, the pyrD pyrimidine biosynthesis mutant, and the aroK mutant, which is defective in aromatic amino acid biosynthesis. The ilvC mutant showed attenuation in C. elegans and D. melanogaster but not in G. mellonella. It is therefore tempting to speculate that in G. mellonella but not in the other infection hosts tested, sufficient amounts of certain metabolites are available to rescue the defects of the ilvC mutant. In contrast to the purD, purF, and purL mutants, the purA mutant exhibited wild-type pathogenicity in both the D. melanogaster and the G. mellonella infection models (Table 3). In silico analysis of the B. cenocepacia H111 genome revealed a homologous gene product (GeneID 358069869) with 51.5% identity to H111 PurA. It is possible that this gene is functionally similar to purA and is able to at least partially rescue the production of adenine-related purines in D. melanogaster and G. mellonella. The quorum-sensing regulator CepR was previously shown to be important for pathogenicity to C. elegans but not to G. mellonella (8), and our results show that this regulator is also not essential for pathogenicity to D. melanogaster (Table 3).

Fig 5
  • Open in new tab
  • Download powerpoint
Fig 5

Virulence of wild-type B. cenocepacia H111 and attenuated auxotrophic Tn5 mutants in the D. melanogaster infection model. Fifteen flies were inoculated with bacterial culture per experiment and incubated at 26°C. Live flies were counted every 24 h postinfection. Data are based on three independent experiments and were analyzed using survival curves generated by the Kaplan-Meier statistical method. The significance of the difference between results for the wild type and the mutants was determined using the log rank (Mantel-Cox) test. For all the tested strains the P value was <0.0001.

Fig 6
  • Open in new tab
  • Download powerpoint
Fig 6

Virulence of wild-type B. cenocepacia H111type, attenuated auxotrophic Tn5 mutants, and complemented mutant strains in the G. mellonella infection model. G. mellonella larvae were infected with approximately 2 × 105 bacteria and incubated at 30°C in the dark. Live and dead larvae were counted after 20, 24, 40, 48, and 72 h postinfection. The curves were calculated using three independent replicates. The significance of the difference between results for the wild type and the Tn5 mutants was determined using the log rank (Mantel-Cox) test and is indicated as follows: *, 0.01 ≤ P ≤ 0.05; **, 0.001 ≤ P ≤ 0.01; ***, P < 0.001.

In summary, five mutants were identified which were attenuated in all three infection hosts used. The genes inactivated in these strains (aroK, pyrD, purD, purF, and purL) may therefore encode factors that are universally important for virulence, whereas the genes inactivated in the other mutants were specific virulence factors for C. elegans and/or D. melanogaster.

Complementation and supplementation of the Tn5 metabolic mutants.The aroK, pyrD, purD, purF, and purL mutants, which showed attenuation in all the animal models tested, were complemented using a B. cenocepacia H111 cosmid library. All complemented mutants were able to grow at the wild-type rate on minimal medium with citrate as a carbon source (see Fig. S2 in the supplemental material). Furthermore, pathogenicity of the complemented mutants was at least partially restored (Fig. 6). Supplementation of nematode growth medium with histidine, cysteine, or adenosine as appropriate restored virulence to wild-type levels in the C. elegans model in all metabolic mutants except the purD mutant, which showed an intermediate level of virulence (Fig. 1; Table 3).

DISCUSSION

Over the past few years, nonmammalian infection models have been established as attractive alternatives to traditional animal models because of their practical advantages, particularly the possibility of performing high-throughput screens. In this study, we used the nematode C. elegans as an infection host to screen a B. cenocepacia H111 mutant library for attenuated strains.

Previous work has shown that the CepIR QS system is crucial for B. cenocepacia virulence in C. elegans, as it controls the expression of factors that contribute to pathogenicity in this infection model (8, 22). The finding that in one of the attenuated mutants the transposon had inactivated cepR and in two other mutants (the rsuA and lon mutants) it had affected the QS circuitry therefore validates the screening strategy. One of the QS-regulated virulence factors that has been shown to be important for killing of C. elegans is the protein AidA, although its mode of action remains to be elucidated (12). Interestingly, AidA has not been found to play a role in any other infection host tested so far, and it thus appears to be a specific virulence factor required for infection of nematodes (8). The finding that the trpA and trpB mutants produce no or greatly reduced amounts of AidA may contribute to the specific attenuation of these strains in the C. elegans model (Table 3). Supplementing the medium with tryptophan restored AidA production as well as virulence of the two mutants (Fig. 1 and data not shown), indicating that the attenuation of the two mutants is not a consequence of a secondary mutation. However, at present it is unclear how trpA and trpB, which are required for tryptophan biosynthesis, affect expression of AidA.

Other QS-regulated virulence factors of B. cenocepacia include the ZmpA and ZmpB proteases and the siderophore pyochelin (8). Proteolytic activity was shown to be important for pathogenicity in mammals but not in invertebrates or alfalfa, likely because they specifically modulate the host immune response of mammals by degrading specific tissue components such as collagen and fibronectin and by obstructing immune proteins (55–57). Hence, the abolished or lowered proteolytic activity observed for several of the mutants (Table 3) does not account for their lowered virulence in the infection models used. However, one would expect that these mutants would be attenuated in mammals. Pyochelin production in B. cenocepacia has been shown to be dependent on the availability of its precursors, salicylic acid and cysteine (58). As expected, all five mutants with insertions in the genes of the cysteine biosynthetic pathway showed a reduction in pyochelin production (Fig. 2) and an increase in the accumulation of its precursor salicylic acid. Likewise, the aroK mutant, which is defective in the biosynthesis of aromatic metabolites, including the pyochelin precursor salicylic acid, did not produce pyochelin.

Our mutant screen identified a few genes that were essential for virulence in all three nonmammalian infection models used in this study. Rather than coding for typical virulence factors, these genes were purF, purD, and purL from the purine biosynthesis pathway, pyrD from the pyrimidine synthesis pathway, and aroK from the shikimate pathway. Given that B. cenocepacia produces a battery of virulence factors (7), the inactivation of just one of these may not greatly affect the overall pathogenicity of the organism, explaining why such factors were not identified in our screen. The genes identified encode enzymes that are critical for essential anabolic pathways, and consequently these mutants were unable to grow in minimal medium. Importantly, auxotrophy per se is not the reason for the reduced virulence of these strains, as we determined that approximately 8% of the mutants in the transposon insertion library were unable to grow in minimal medium. This suggests that it is the lack or shortage of specific metabolites in each infection host that causes attenuation. In agreement with this hypothesis, we observed that nematode pathogenicity of the mutants could be restored to wild-type levels by supplementing the medium with appropriate metabolites (Fig. 1). It is important to note, however, that on NG medium, which was used for the C. elegans assays, the mutants showed no growth defects, suggesting that the reduced virulence is not a just a consequence of a lowered infection dose. In the case of the aroK mutant, we tested whether the strain could persist within infected G. mellonella larvae. At 8 days postinfection the animals did not show any disease symptoms, yet we were able to isolate the mutant from the hemolymph of the larvae (approximately 550 bacteria per μl), demonstrating that the bacteria were capable of in vivo survival. We hypothesize that the nutritional environment in the infection host supports persistence of the mutant but neither significant growth nor energy-consuming virulence factor production.

Although it remains to be determined whether our B. cenocepacia mutants are also attenuated in a mammalian infection host, it is notable that the same metabolic pathways have been identified as key systems in virulence in murine models. De novo purine biosynthesis has been shown to be essential for the virulence of a variety of pathogens, including Francisella tularensis (59), Salmonella enterica serovar Typhimurium (60), Staphylococcus aureus (61), Streptococcus pneumoniae (62), Yersinia pestis (63), Vibrio vulnificus (64), Bacillus anthracis (54, 65), Brucella melitensis (66), and Brucella abortus (67). Previous work has also shown that in V. vulnificus, pyrimidine biosynthetic genes are preferentially expressed during infection, and a pyrH mutant was attenuated in virulence (64, 68). In Listeria monocytogenes, both purine and pyrimidine biosynthetic genes were found to be upregulated in infected mammalian cells (69). In a recent study, it was demonstrated that de novo nucleotide biosynthesis is critical for survival and growth of bacteria in human serum, and therefore the purine and pyrimidine biosynthetic pathways are essential for proliferation of bacterial pathogens in the bloodstream (70). Finally, the shikimate pathway, of which the AroK protein is a part, has been demonstrated to be required for virulence of S. enterica serovar Typhimurium (71), P. aeruginosa (72), and L. monocytogenes (73). Most interestingly in the context of this study is the finding that inactivation of aroB, which is required for shikimate biosynthesis in Burkholderia pseudomallei, the causative agent of melioidosis, renders the organism avirulent. Moreover, murine challenge studies revealed partial protection in BALB/c mice vaccinated with an aroB mutant (74). Given that the shikimate pathway is crucial to bacteria but missing in mammals (75), the enzymes involved in this pathway have been considered particularly interesting drug targets for developing nontoxic antimicrobial agents (76).

In summary, we have identified several genes in B. cenocepacia that are critical for pathogenicity in multiple nonmammalian infection hosts. These results not only further our understanding of the virulence mechanisms used by this opportunistic pathogen but also have led to the identification of some potential targets for the development of novel antibacterial drugs. Some of the strongly attenuated mutants identified in this study could also be of interest for the development of live vaccines.

ACKNOWLEDGMENTS

This work has been supported by the Swiss National Science Foundation (projects 31003A-122013 and 143773) and the Danish Council for Strategic Research (CAR project).

FOOTNOTES

    • Received 24 July 2012.
    • Returned for modification 28 August 2012.
    • Accepted 15 October 2012.
    • Accepted manuscript posted online 22 October 2012.
  • Supplemental material for this article may be found at http://dx.doi.org/10.1128/IAI.00768-12.

  • Copyright © 2013, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Coenye T,
    2. Vandamme P
    . 2003. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ. Microbiol. 5:719–729.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Eberl L,
    2. Tummler B
    . 2004. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int. J. Med. Microbiol. 294:123–131.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Mahenthiralingam E,
    2. Baldwin A,
    3. Dowson CG
    . 2008. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J. Appl. Microbiol. 104:1539–1551.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Mahenthiralingam E,
    2. Urban TA,
    3. Goldberg JB
    . 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3:144–156.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Isles A,
    2. Maclusky I,
    3. Corey M,
    4. Gold R,
    5. Prober C,
    6. Fleming P,
    7. Levison H
    . 1984. Pseudomonas cepacia infection in cystic-fibrosis—an emerging problem. J. Pediatr. 104:206–210.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Baldwin A,
    2. Sokol PA,
    3. Parkhill J,
    4. Mahenthiralingam E
    . 2004. The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect. Immun. 72:1537–1547.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Loutet SA,
    2. Valvano MA
    . 2010. A decade of Burkholderia cenocepacia virulence determinant research. Infect. Immun. 78:4088–4100.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Uehlinger S,
    2. Schwager S,
    3. Bernier SP,
    4. Riedel K,
    5. Nguyen DT,
    6. Sokol PA,
    7. Eberl L
    . 2009. Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect. Immun. 77:4102–4110.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Castonguay-Vanier J,
    2. Vial L,
    3. Tremblay J,
    4. Deziel E
    . 2010. Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS One 5:e11467. doi:10.1371/journal.pone.0011467.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Apidianakis Y,
    2. Rahme LG
    . 2009. Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection. Nat. Protoc. 4:1285–1294.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Seed KD,
    2. Dennis JJ
    . 2008. Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect. Immun. 76:1267–1275.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Huber B,
    2. Feldmann F,
    3. Kothe M,
    4. Vandamme P,
    5. Wopperer J,
    6. Riedel K,
    7. Eberl L
    . 2004. Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect. Immun. 72:7220–7230.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Bertani G
    . 1951. Studies on lysogenesis. 1. The mode of phage liberation by lysogenic Escherichia coli. J. Bacteriol. 62:293–300.
    OpenUrlFREE Full Text
  14. 14.↵
    1. Tan MW,
    2. Rahme LG,
    3. Sternberg JA,
    4. Tompkins RG,
    5. Ausubel FM
    . 1999. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl. Acad. Sci. U. S. A. 96:2408–2413.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Brenner S
    . 1974. Genetics of Caenorhabditis elegans. Genetics 77:71–94.
    OpenUrlPubMedWeb of Science
  16. 16.↵
    1. Sambrook J,
    2. Fritsch EF,
    3. Maniatis T
    . 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  17. 17.↵
    1. Southern EM
    . 1975. Detection of specific sequences among DNA fragments separated by gel-electrophoresis. J. Mol. Biol. 98:503–517.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. O'Toole GA,
    2. Kolter R
    . 1998. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449–461.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Better M,
    2. Lewis B,
    3. Corbin D,
    4. Ditta G,
    5. Helinski DR
    . 1983. Structural relationships among Rhizobium meliloti symbiotic promoters. Cell 35:479–485.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Vandeneede G,
    2. Deblaere R,
    3. Goethals K,
    4. Vanmontagu M,
    5. Holsters M
    . 1992. Broad host range and promoter selection vectors for bacteria that interact with plants. Mol. Plant Microbe Interact. 5:228–234.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    1. de Lorenzo V,
    2. Timmis KN
    . 1994. Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5-derived and Tn10-derived minitransposons. Methods Enzymol. 235:386–405.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Köthe M,
    2. Antl M,
    3. Huber B,
    4. Stoecker K,
    5. Ebrecht D,
    6. Steinmetz I,
    7. Eberl L
    . 2003. Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system. Cell. Microbiol. 5:343–351.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Cardona ST,
    2. Wopperer J,
    3. Eberl L,
    4. Valvano MA
    . 2005. Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol. Lett. 250:97–104.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Stiernagle T,
    2. Hope IA
    (ed). 1999. C. elegans: a practical approach. Oxford University Press, New York, NY.
  25. 25.↵
    1. Schwyn B,
    2. Neilands JB
    . 1987. Universal chemical-assay for the detection and determination of siderophores. Anal. Biochem. 160:47–56.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Lewenza S,
    2. Conway B,
    3. Greenberg EP,
    4. Sokol PA
    . 1999. Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J. Bacteriol. 181:748–756.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Visca P,
    2. Ciervo A,
    3. Sanfilippo V,
    4. Orsi N
    . 1993. Iron-regulated salicylate synthesis by Pseudomonas spp. J. Gen. Microbiol. 139:1995–2001.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Rinehart KL,
    2. Staley AL,
    3. Wilson SR,
    4. Ankenbauer RG,
    5. Cox CD
    . 1995. Stereochemical assignment of the pyochelins. J. Org. Chem. 60:2786–2791.
    OpenUrlCrossRef
  29. 29.↵
    1. Ankenbauer RG,
    2. Toyokuni T,
    3. Staley A,
    4. Rinehart KL Jr,
    5. Cox CD
    . 1988. Synthesis and biological activity of pyochelin, a siderophore of Pseudomonas aeruginosa. J. Bacteriol. 170:5344–5351.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Gerhardt P,
    2. Murray RGE,
    3. Costilow RN,
    4. Nester EW,
    5. Wood WA,
    6. Krieg NR,
    7. Phillips GB
    (ed). 1981. Manual of methods for general bacteriology. American Society for Microbiology, Washington, DC.
  31. 31.↵
    1. Sage A,
    2. Linker A,
    3. Evans LR,
    4. Lessie TG
    . 1990. Hexose phosphate-metabolism and exopolysaccharide formation in Pseudomonas cepacia. Curr. Microbiol. 20:191–198.
    OpenUrlCrossRef
  32. 32.↵
    1. Clark DJ,
    2. Maaloe O
    . 1967. DNA replication and division cycle in Escherichia coli. J. Mol. Biol. 23:99–112.
    OpenUrlCrossRefWeb of Science
  33. 33.↵
    1. Sokol PA,
    2. Darling P,
    3. Woods DE,
    4. Mahenthiralingam E,
    5. Kooi C
    . 1999. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding l-ornithine N-5-oxygenase. Infect. Immun. 67:4443–4455.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Visser MB,
    2. Majumdar S,
    3. Hani E,
    4. Sokol PA
    . 2004. Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect. Immun. 72:2850–2857.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Malott RJ,
    2. O'Grady EP,
    3. Toller J,
    4. Inhuelsen S,
    5. Eberl L,
    6. Sokol PA
    . 2009. A Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing regulation. J. Bacteriol. 191:2447–2460.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Chung JW,
    2. Altman E,
    3. Beveridge TJ,
    4. Speert DP
    . 2003. Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect. Immun. 71:904–909.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Cunha MV,
    2. Sousa SA,
    3. Leitao JH,
    4. Moreira LM,
    5. Videira PA,
    6. SA-Correia I
    . 2004. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J. Clin. Microbiol. 42:3052–3058.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Bartholdson SJ,
    2. Brown AR,
    3. Mewburn BR,
    4. Clarke DJ,
    5. Fry SC,
    6. Campopiano DJ,
    7. Govan JR
    . 2008. Plant host and sugar alcohol induced exopolysaccharide biosynthesis in the Burkholderia cepacia complex. Microbiology 154:2513–2521.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Ferreira AS,
    2. Leitao JH,
    3. Silva IN,
    4. Pinheiro PF,
    5. Sousa SA,
    6. Ramos CG,
    7. Moreira LM
    . 2010. Distribution of cepacian biosynthesis genes among environmental and clinical Burkholderia strains and role of cepacian exopolysaccharide in resistance to stress conditions. Appl. Environ. Microbiol. 76:441–450.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Conway BA,
    2. Chu KK,
    3. Bylund J,
    4. Altman E,
    5. Speert DP
    . 2004. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J. Infect. Dis. 190:957–966.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Sousa SA,
    2. Ulrich M,
    3. Bragonzi A,
    4. Burke M,
    5. Worlitzsch D,
    6. Leitao JH,
    7. Meisner C,
    8. Eberl L,
    9. SA-Correia I,
    10. Doring G
    . 2007. Virulence of Burkholderia cepacia complex strains in gp91phox−/− mice. Cell. Microbiol. 9:2817–2825.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Agnoli K,
    2. Schwager S,
    3. Uehlinger S,
    4. Vergunst A,
    5. Viteri DF,
    6. Nguyen DT,
    7. Sokol PA,
    8. Carlier A,
    9. Eberl L
    . 2012. Exposing the third chromosome of Burkholderia cepacia complex strains as a virulence plasmid. Mol. Microbiol. 83:362–378.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Huber B,
    2. Riedel K,
    3. Kothe M,
    4. Givskov M,
    5. Molin S,
    6. Eberl L
    . 2002. Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111. Mol. Microbiol. 46:411–426.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Van Melderen L,
    2. Aertsen A
    . 2009. Regulation and quality control by Lon-dependent proteolysis. Res. Microbiol. 160:645–651.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    1. Snider J,
    2. Thibault G,
    3. Houry WA
    . 2008. The AAA plus superfamily of functionally diverse proteins. Genome Biology 9:216.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Takaya A,
    2. Suzuki M,
    3. Matsui H,
    4. Tomoyasu T,
    5. Sashinami H,
    6. Nakane A,
    7. Yamamoto T
    . 2003. Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enterica serovar Typhimurium infection of mice. Infect. Immun. 71:690–696.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Lan L,
    2. Deng X,
    3. Xiao Y,
    4. Zhou J-M,
    5. Tang X
    . 2007. Mutation of Lon protease differentially affects the expression of Pseudomonas syringae type III secretion system genes in rich and minimal media and reduces pathogenicity. Mol. Plant Microbe Interact. 20:682–696.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Cohn MT,
    2. Ingmer H,
    3. Mulholland F,
    4. Jorgensen K,
    5. Wells JM,
    6. Brondsted L
    . 2007. Contribution of conserved ATP-dependent proteases of Campylobacter jejuni to stress tolerance and virulence. Appl. Environ. Microbiol. 73:7803–7813.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Su SC,
    2. Stephens BB,
    3. Alexandre G,
    4. Farrand SK
    . 2006. Lon protease of the alpha-proteobacterium Agrobacterium tumefaciens is required for normal growth, cellular morphology and full virulence. Microbiology 152:1197–1207.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    1. Robertson GT,
    2. Kovach ME,
    3. Allen CA,
    4. Ficht TA,
    5. Roop RM
    . 2000. The Brucella abortus Lon functions as a generalized stress response protease and is required for wild-type virulence in BALB/c mice. Mol. Microbiol. 35:577–588.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Butler SM,
    2. Festa RA,
    3. Pearce MJ,
    4. Darwin KH
    . 2006. Self-compartmentalized bacterial proteases and pathogenesis. Mol. Microbiol. 60:553–562.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    1. Tsilibaris V,
    2. Maenhaut-Michel G,
    3. Van Melderen L
    . 2006. Biological roles of the Lon ATP-dependent protease. Res. Microbiol. 157:701–713.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    1. Zhang Y,
    2. Morar M,
    3. Ealick SE
    . 2008. Structural biology of the purine biosynthetic pathway. Cell. Mol. Life Sci. 65:3699–3724.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Jenkins A,
    2. Cote C,
    3. Twenhafel N,
    4. Merkel T,
    5. Bozue J,
    6. Welkos S
    . 2011. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infect. Immun. 79:153–166.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Corbett CR,
    2. Burtnick MN,
    3. Kooi C,
    4. Woods DE,
    5. Sokol PA
    . 2003. An extracellular zinc metalloprotease gene of Burkholderia cepacia. Microbiology 149:2263–2271.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Kooi C,
    2. Subsin B,
    3. Chen R,
    4. Pohorelic B,
    5. Sokol PA
    . 2006. Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect. Immun. 74:4083–4093.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Kooi C,
    2. Corbett CR,
    3. Sokol PA
    . 2005. Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease. J. Bacteriol. 187:4421–4429.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    1. Farmer KL,
    2. Thomas MS
    . 2004. Isolation and characterization of Burkholderia cenocepacia mutants deficient in pyochelin production: pyochelin biosynthesis is sensitive to sulfur availability. J. Bacteriol. 186:270–277.
    OpenUrlAbstract/FREE Full Text
  59. 59.↵
    1. Meibom KL,
    2. Charbit A
    . 2010. Francisella tularensis metabolism and its relation to virulence. Front. Microbiol. 1:140.
    OpenUrlCrossRefPubMed
  60. 60.↵
    1. Hoiseth SK,
    2. Stocker BAD
    . 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238–239.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Mei JM,
    2. Nourbakhsh F,
    3. Ford CW,
    4. Holden DW
    . 1997. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. 26:399–407.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    1. Polissi A,
    2. Pontiggia A,
    3. Feger G,
    4. Altieri M,
    5. Mottl H,
    6. Ferrari L,
    7. Simon D
    . 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. 66:5620–5629.
    OpenUrlAbstract/FREE Full Text
  63. 63.↵
    1. Brubaker RR
    . 1970. Interconversion of purine mononucleotides in Pasteurella pestis. Infect. Immun. 1:446–454.
    OpenUrlAbstract/FREE Full Text
  64. 64.↵
    1. Kim YR,
    2. Lee SE,
    3. Kim CM,
    4. Kim SY,
    5. Shin EK,
    6. Shin DH,
    7. Chung SS,
    8. Choy HE,
    9. Progulske-Fox A,
    10. Hillman JD,
    11. Handfield M,
    12. Rhee JH
    . 2003. Characterization and pathogenic significance of Vibrio vulnificus antigens preferentially expressed in septicemic patients. Infect. Immun. 71:5461–5471.
    OpenUrlAbstract/FREE Full Text
  65. 65.↵
    1. Ivanovics G,
    2. Marjai E,
    3. Dobozy A
    . 1968. The growth of purine mutants of Bacillus anthracis in the body of the mouse. J. Gen. Microbiol. 53:147–162.
    OpenUrlCrossRefPubMedWeb of Science
  66. 66.↵
    1. Crawford RM,
    2. Van De Verg L,
    3. Yuan L,
    4. Hadfield TL,
    5. Warren RL,
    6. Drazek ES,
    7. Houng HH,
    8. Hammack C,
    9. Sasala K,
    10. Polsinelli T,
    11. Thompson J,
    12. Hoover DL
    . 1996. Deletion of purE attenuates Brucella melitensis infection in mice. Infect. Immun. 64:2188–2192.
    OpenUrlAbstract/FREE Full Text
  67. 67.↵
    1. Alcantara RB,
    2. Read RDA,
    3. Valderas MW,
    4. Brown TD,
    5. Roop RM
    . 2004. Intact purine biosynthesis pathways are required for wild-type virulence of Brucella abortus 2308 in the BALB/c mouse model. Infect. Immun. 72:4911–4917.
    OpenUrlAbstract/FREE Full Text
  68. 68.↵
    1. Lee SE,
    2. Kim SY,
    3. Kim CM,
    4. Kim MK,
    5. Kim YR,
    6. Jeong K,
    7. Ryu HJ,
    8. Lee YS,
    9. Chung SS,
    10. Choy HE,
    11. Rhee JH
    . 2007. The pyrH gene of Vibrio vulnificus is an essential in vivo survival factor. Infect. Immun. 75:2795–2801.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Klarsfeld AD,
    2. Goossens PL,
    3. Cossart P
    . 1994. Five Listeria monocytogenes genes preferentially expressed in infected mammalian cells: plcA, purH, purD, pyrE and an arginine ABC transporter gene, arpJ. Mol. Microbiol. 13:585–597.
    OpenUrlCrossRefPubMedWeb of Science
  70. 70.↵
    1. Samant S,
    2. Lee H,
    3. Ghassemi M,
    4. Chen J,
    5. Cook JL,
    6. Mankin AS,
    7. Neyfakh AA
    . 2008. Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog. 4:e37. doi:10.1371/journal.ppat.0040037.
    OpenUrlCrossRefPubMed
  71. 71.↵
    1. Gunel-Ozcan A,
    2. Brown KA,
    3. Allen AG,
    4. Maskell DJ
    . 1997. Salmonella typhimurium aroB mutants are attentuated in BALB/c mice. Microb. Pathog. 23:311–316.
    OpenUrlCrossRefPubMed
  72. 72.↵
    1. Priebe GP,
    2. Meluleni GJ,
    3. Coleman FT,
    4. Goldberg JB,
    5. Pier GB
    . 2003. Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect. Immun. 71:1453–1461.
    OpenUrlAbstract/FREE Full Text
  73. 73.↵
    1. Stritzker J,
    2. Janda J,
    3. Schoen C,
    4. Taupp M,
    5. Pilgrim S,
    6. Gentschev I,
    7. Schreier P,
    8. Geginat G,
    9. Goebel W
    . 2004. Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants. Infect. Immun. 72:5622–5629.
    OpenUrlAbstract/FREE Full Text
  74. 74.↵
    1. Cuccui J,
    2. Easton A,
    3. Chu KK,
    4. Bancroft GJ,
    5. Oyston PCF,
    6. Titball RW,
    7. Wren BW
    . 2007. Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect. Immun. 75:1186–1195.
    OpenUrlAbstract/FREE Full Text
  75. 75.↵
    1. Roberts F,
    2. Roberts CW,
    3. Johnson JJ,
    4. Kyle DE,
    5. Krell T,
    6. Coggins JR,
    7. Coombs GH,
    8. Milhous WK,
    9. Tzipori S,
    10. Ferguson DJP,
    11. Chakrabarti D,
    12. McLeod R
    . 1998. Evidence for the shikimate pathway in apicomplexan parasites. Nature 393:801–805.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    1. Coggins JR,
    2. Abell C,
    3. Evan LB,
    4. Frederickson M,
    5. Robinson DA,
    6. Roszak AW,
    7. Lapthorn AP
    . 2003. Experiences with the shikimate-pathway enzymes as targets for rational drug design. Biochem. Soc. Trans. 31:548–552.
    OpenUrlCrossRefPubMedWeb of Science
  77. 77.
    1. Steidle A,
    2. Sigl K,
    3. Schuhegger R,
    4. Ihring A,
    5. Schmid M,
    6. Gantner S,
    7. Stoffels M,
    8. Riedel K,
    9. Givskov M,
    10. Hartmann A,
    11. Langebartels C,
    12. Eberl L
    . 2001. Visualization of N-acylhomoserine lactone-mediated cell-cell communication between bacteria colonizing the tomato rhizosphere. Appl. Environ. Microbiol. 67:5761–5770.
    OpenUrlAbstract/FREE Full Text
  78. 78.
    1. Romling U,
    2. Fiedler B,
    3. Bosshammer J,
    4. Grothues D,
    5. Greipel J,
    6. von der Hardt H,
    7. Tummler B
    . 1994. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170:1616–1621.
    OpenUrlCrossRefPubMedWeb of Science
  79. 79.
    1. Huber B,
    2. Riedel K,
    3. Hentzer M,
    4. Heydorn A,
    5. Gotschlich A,
    6. Givskov M,
    7. Molin S,
    8. Eberl L
    . 2001. The cep quorum-sensing system of Burkholderia cepacia H111 controls biofilm formation and swarming motility. Microbiology 147:2517–2528.
    OpenUrlCrossRefPubMedWeb of Science
  80. 80.
    1. Winson MK,
    2. Swift S,
    3. Fish L,
    4. Throup JP,
    5. Jorgensen F,
    6. Chhabra SR,
    7. Bycroft BW,
    8. Williams P,
    9. Stewart G
    . 1998. Construction and analysis of luxCDABE-based plasmid sensors for investigating N-acyl homoserine lactone-mediated quorum sensing. FEMS Microbiol. Lett. 163:185–192.
    OpenUrlCrossRefPubMedWeb of Science
  81. 81.
    1. Winson MK,
    2. Swift S,
    3. Hill PJ,
    4. Sims CM,
    5. Griesmayr G,
    6. Bycroft BW,
    7. Williams P,
    8. Stewart G
    . 1998. Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructs. FEMS Microbiol. Lett. 163:193–202.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Identification of Burkholderia cenocepacia Strain H111 Virulence Factors Using Nonmammalian Infection Hosts
Stephan Schwager, Kirsty Agnoli, Manuela Köthe, Friederike Feldmann, Michael Givskov, Aurelien Carlier, Leo Eberl
Infection and Immunity Dec 2012, 81 (1) 143-153; DOI: 10.1128/IAI.00768-12

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Infection and Immunity article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of Burkholderia cenocepacia Strain H111 Virulence Factors Using Nonmammalian Infection Hosts
(Your Name) has forwarded a page to you from Infection and Immunity
(Your Name) thought you would be interested in this article in Infection and Immunity.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of Burkholderia cenocepacia Strain H111 Virulence Factors Using Nonmammalian Infection Hosts
Stephan Schwager, Kirsty Agnoli, Manuela Köthe, Friederike Feldmann, Michael Givskov, Aurelien Carlier, Leo Eberl
Infection and Immunity Dec 2012, 81 (1) 143-153; DOI: 10.1128/IAI.00768-12
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About IAI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #IAIjournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0019-9567; Online ISSN: 1098-5522